Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise
SR Gameiro, ML Jammeh, JW Hodge - Expert review of vaccines, 2013 - Taylor & Francis
Concurrent with the US FDA's approval of the first therapeutic cancer vaccine, and
supported by mounting clinical evidence indicating that targeting carcinoembryonic antigen …
supported by mounting clinical evidence indicating that targeting carcinoembryonic antigen …
Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials
M Turriziani, M Fantini, M Benvenuto… - Recent patents on …, 2012 - ingentaconnect.com
Carcinoembryonic antigen (CEA), a glycosylated protein of MW 180 kDa, is overexpressed
in a wide range of human carcinomas, including colorectal, gastric, pancreatic, non-small …
in a wide range of human carcinomas, including colorectal, gastric, pancreatic, non-small …
Strategies for cancer therapy using carcinoembryonic antigen vaccines
HL Kaufman, H Hörig, FA Medina, S Golding… - Expert reviews in …, 2000 - cambridge.org
Advances in molecular biology and immunology have renewed interest in the development
of vaccines for the treatment or prevention of cancer. Research over the past 10 years has …
of vaccines for the treatment or prevention of cancer. Research over the past 10 years has …
Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review
NL Berinstein - Journal of Clinical Oncology, 2002 - ascopubs.org
PURPOSE: To describe the features of carcinoembryonic antigen (CEA) that are important
for its use in vaccination approaches and review the clinical experience with therapeutic …
for its use in vaccination approaches and review the clinical experience with therapeutic …
Therapeutic cancer vaccines: current status and moving forward
J Schlom - Journal of the National Cancer Institute, 2012 - academic.oup.com
Concurrent with US Food and Drug Administration (FDA) approval of the first therapeutic
cancer vaccine, a wide spectrum of other cancer vaccine platforms that target a diverse …
cancer vaccine, a wide spectrum of other cancer vaccine platforms that target a diverse …
Cancer Vaccines in the Immunotherapy Era: Promise and Potential
C Verma, VA Pawar, S Srivastava, A Tyagi, G Kaushik… - Vaccines, 2023 - mdpi.com
Therapeutic vaccines are a promising alternative for active immunotherapy for different types
of cancers. Therapeutic cancer vaccines aim to prevent immune system responses that are …
of cancers. Therapeutic cancer vaccines aim to prevent immune system responses that are …
Therapeutic cancer vaccines: advancements, challenges, and prospects
T Fan, M Zhang, J Yang, Z Zhu, W Cao… - Signal Transduction and …, 2023 - nature.com
With the development and regulatory approval of immune checkpoint inhibitors and adoptive
cell therapies, cancer immunotherapy has undergone a profound transformation over the …
cell therapies, cancer immunotherapy has undergone a profound transformation over the …
Cancer vaccine therapeutics: limitations and effectiveness—A literature review
M Kaczmarek, J Poznańska, F Fechner, N Michalska… - Cells, 2023 - mdpi.com
In recent years, there has been a surge of interest in tumor microenvironment-associated
cancer vaccine therapies. These innovative treatments aim to activate and enhance the …
cancer vaccine therapies. These innovative treatments aim to activate and enhance the …
What's next for cancer vaccines
J Adamik, LH Butterfield - Science Translational Medicine, 2022 - science.org
Cancer vaccines have been shown clinically to drive tumor-reactive cell activation,
proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer …
proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer …